Terms: = Lung cancer AND TOP1, RP3-511B24_2, 7150, ENSG00000198900, TOPI, P11387 AND Staging
3564 results:
1. HBB as a Novel Biomarker for the Diagnosis and Monitoring of lung cancer Regulates Cell Proliferation via ERK1/2 Pathway.
Xu X; Cai H; Peng J; Liu H; Chu F
Technol Cancer Res Treat; 2024; 23():15330338241249032. PubMed ID: 38679728
[No Abstract] [Full Text] [Related]
2. A practical nomogram for predicting early death in elderly small cell lung cancer patients: A SEER-based study.
Chen R; Liu Y; Tou F; Xie J
Medicine (Baltimore); 2024 Apr; 103(17):e37759. PubMed ID: 38669410
[TBL] [Abstract] [Full Text] [Related]
3. [Construction and Validation of Prediction Models of Risk Factors for Early Death in Patients With Metastatic Melanoma].
Li S; Li J; Yang Q; Yin C; Liu B
Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Mar; 55(2):367-374. PubMed ID: 38645854
[TBL] [Abstract] [Full Text] [Related]
4. Clinical values of different specimen preparation methods for the diagnosis of lung cancer by EBUS-TBNA.
Wang H; Wang J; Liu Y; Wang Y; Zhou Y; Yu D; You H; Ren T; Tang Y; Wang M
Diagn Pathol; 2024 Apr; 19(1):61. PubMed ID: 38641621
[TBL] [Abstract] [Full Text] [Related]
5. Alectinib in Resected
Wu YL; Dziadziuszko R; Ahn JS; Barlesi F; Nishio M; Lee DH; Lee JS; Zhong W; Horinouchi H; Mao W; Hochmair M; de Marinis F; Migliorino MR; Bondarenko I; Lu S; Wang Q; Ochi Lohmann T; Xu T; Cardona A; Ruf T; Noe J; Solomon BJ;
N Engl J Med; 2024 Apr; 390(14):1265-1276. PubMed ID: 38598794
[TBL] [Abstract] [Full Text] [Related]
6. High risk of lung cancer in surfactant-related gene variant carriers.
Brudon A; Legendre M; Mageau A; Bermudez J; Bonniaud P; Bouvry D; Cadranel J; Cazes A; Crestani B; Dégot T; Delestrain C; Diesler R; Epaud R; Philippot Q; Théou-Anton N; Kannengiesser C; Ba I; Debray MP; Fanen P; Manali E; Papiris S; Nathan N; Amselem S; Gondouin A; Guillaumot A; Andréjak C; Jouneau S; Beltramo G; Uzunhan Y; Galodé F; Westeel V; Mehdaoui A; Hirschi S; Leroy S; Marchand-Adam S; Nunes H; Picard C; Prévot G; Reynaud-Gaubert M; De Vuyst P; Wemeau L; Defossez G; Zalcman G; Cottin V; Borie R;
Eur Respir J; 2024 May; 63(5):. PubMed ID: 38575158
[TBL] [Abstract] [Full Text] [Related]
7. The radiological characteristics, tertiary lymphoid structures, and survival status associated with EGFR mutation in patients with subsolid nodules like stage I-II LUAD.
Xie M; Gao J; Ma X; Song J; Wu C; Zhou Y; Jiang T; Liang Y; Yang C; Bao X; Zhang X; Yao J; Jing Y; Wu J; Wang J; Xue X
BMC Cancer; 2024 Mar; 24(1):372. PubMed ID: 38528507
[TBL] [Abstract] [Full Text] [Related]
8. Validation of an Updated Algorithm to Identify Patients With Incident Non-Small Cell lung cancer in Administrative Claims Databases.
Patel SP; Wang R; Zhou SQ; Sheinson D; Johnson A; Lee JS
JCO Clin Cancer Inform; 2024 Mar; 8():e2300165. PubMed ID: 38502111
[TBL] [Abstract] [Full Text] [Related]
9. The association of visceral pleural invasion with skip N2 metastasis on clinical stage IA NSCLC.
Minamoto F; Araújo P; D'Ambrosio P; Dela Vega A; Lauricella L; Pêgo-Fernandes P; Terra R
Clinics (Sao Paulo); 2024; 79():100334. PubMed ID: 38484584
[TBL] [Abstract] [Full Text] [Related]
10. lung cancer Diagnoses and Outcomes During the Syrian War, 2011-2018.
Hanafi I; Abo Samra D; Alsaqqa R; Naeem A; Shebli B; Ajlyakin G
JAMA Netw Open; 2024 Mar; 7(3):e242091. PubMed ID: 38477917
[TBL] [Abstract] [Full Text] [Related]
11. Validation of the 9th edition of the TNM staging system for non-small cell lung cancer with lobectomy in stage IA-IIIA.
Wang RR; Li MJ; Peng Q; Huang ZY; Wu LL; Xie D
Eur J Cardiothorac Surg; 2024 Mar; 65(3):. PubMed ID: 38426334
[TBL] [Abstract] [Full Text] [Related]
12. Factors affecting accuracy of clinical staging in resectable non-small cell lung cancer in a real-world study.
Gwon HR; La Woo A; Yong SH; Park Y; Kim SY; Kim EY; Jung JY; Kang YA; Park MS; Park SY; Lee SH
Thorac Cancer; 2024 Mar; 15(9):730-737. PubMed ID: 38380557
[TBL] [Abstract] [Full Text] [Related]
13. Integration of on-treatment modified Glasgow prognostic score (mGPS) to improve imaging-based prediction of outcomes in patients with non-small cell lung cancer on immune checkpoint inhibition.
Saal J; Bald T; Eckstein M; Ralser DJ; Brossart P; Ellinger J; Hölzel M; Klümper N
Lung Cancer; 2024 Mar; 189():107505. PubMed ID: 38367405
[TBL] [Abstract] [Full Text] [Related]
14. Ductal prostate cancer staging: Role of PSMA PET/CT.
Pepe P; Pepe L; Curduman M; Pennisi M; Fraggetta F
Arch Ital Urol Androl; 2024 Feb; 96(1):12132. PubMed ID: 38363231
[TBL] [Abstract] [Full Text] [Related]
15. Correlation Analysis of KCNQ1 Gene Polymorphism with Blood Indexes and Prognosis of Non-Small Cell lung cancer.
Xie G; Yang Y; Zeng W; Liu Y; Gui B
Clin Lab; 2024 Feb; 70(2):. PubMed ID: 38345992
[TBL] [Abstract] [Full Text] [Related]
16. Outcomes Of Surgically Treated N2-Positive Non-Small Cell lung cancer.
Rei J; Castro P; Guerra M; Miranda J
Port J Card Thorac Vasc Surg; 2024 Feb; 30(4):23-29. PubMed ID: 38345887
[TBL] [Abstract] [Full Text] [Related]
17. Bone marrow biopsy in geriatric patients above the age of 85 years: invaluable or unnecessary? A retrospective analysis.
Zhang KD; Jost E; Panse J; Herwartz R; Lindemann-Docter K; Jonigk D; Kricheldorf K; Köchel A; Sauerbrunn N; Brümmendorf TH; Koschmieder S; Isfort S
Ann Hematol; 2024 Apr; 103(4):1149-1158. PubMed ID: 38336973
[TBL] [Abstract] [Full Text] [Related]
18. A novel investigation into the negative impact of opioid use on the efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients.
Guo H; Li Y; Lin J; Li D; Yang J; Wang J; Mao J; Wang Y; Yan X
Int Immunopharmacol; 2024 Mar; 129():111611. PubMed ID: 38325047
[TBL] [Abstract] [Full Text] [Related]
19. The value of the first postoperative diagnostic I-131 scan in patients with papillary thyroid carcinoma.
Ran B; Shang J; Chen Y; Zhou M; Li H; He W; Li Y; Cai Q; Guo B; Gong J; Xu H
J Cancer Res Clin Oncol; 2024 Feb; 150(2):80. PubMed ID: 38319395
[TBL] [Abstract] [Full Text] [Related]
20. International reproducibility study of thymic epithelial tumors staging: pT stage is an issue. proposals for improvement. A RYTHMIC/ITMIG study.
Molina TJ; Roden AC; Szolkowska M; Shimizu S; Moreira AL; Chalabreysse L; Besse B; de Montpréville V; Marom EM; Detterbeck F; Girard N; Nicholson AG; Marx A
Lung Cancer; 2024 Mar; 189():107479. PubMed ID: 38306885
[TBL] [Abstract] [Full Text] [Related]
[Next]
